Novartis Ag v. Natco Pharma Limited & Anr.

172217691

Novartis Ag appealed against an order that set aside a patent grant (IN'414518) on the ground of procedural lapses. Novartis argued that the Single Judge misinterpreted Rule 55, which pertains only to pre-grant opposition procedures, not application examination under Sections 13, 14, and 15 of the Patents Act, 1970. The Court found issues regarding the merging of proceedings and directed notice to be issued.

Jurisdiction
India
Court
Delhi High Court - Orders
Case Number
172217691
Judge(s)
Manmohan

Detailed Summary

A granted patent is the ultimate prize for an innovator, representing years of research and development finally secured by law. But what happens when a procedural

Practitioner Note

This case demonstrates the evidentiary and procedural standards applied in patent matters before Delhi High Court - Orders. Understanding the court's reasoning in Novartis Ag vs Natco Pharma Limited & Anr. is valuable context for structuring arguments or assessing risk in similar proceedings.

Related Cases

patent77143843

Novartis AgvsCipla Ltd

This Delhi High Court judgment addressed the jurisdictional scope of an ongoing patent infringement suit (CS No.3812/2014) between Novartis Ag and Cipla Ltd. The core issue was whether the case, despite its low pecuniary valuation, should be transferred to a subordinate District Court under the Commercial Courts Ordinance, 2015. The court ruled that because the defendant had filed a counterclaim challenging the patent's validity, the matter must remain before the High Court's Commercial Division, irrespective of the suit's value.

patent132866481

Gsp Crop Science Private LimitedvsFmc Agro Singapore Pte Ltd. & Ors.

GSP Crop Science Private Limited filed a revocation petition challenging the validity of Indian patent no. 298645 (IN645) granted to FMC Agro Singapore Pte Ltd. The petitioner argued that IN645 is invalid because its main patent has expired and it suffers from anticipation by prior claims.

patent115885328

Incyte Holdings CorporationvsBigbear Pharmaceutical (Lao) Co., Ltd

The Plaintiffs filed a suit seeking permanent injunction against the Defendants for infringing Indian Patent No. 269841 related to Ruxolitinib compounds. The court passed several orders granting exemptions from pre-institution mediation and advance service, and appointed Local Commissioners to inspect the alleged infringing activities.

patent186375170

Tak Technologies Private LimitedvsSagi Faifer & Anr.

Tak Technologies Private Limited filed a petition seeking the revocation of Indian Patent No. 477619 held by Mr. Sagi Faifer. The court issued notice and directed Respondent No. 1 to file a reply within four weeks.

patent18877830

M/S.Kaleesuwari Refinery Pvt. Ltd.vsSri Durgai Oil Stores

M/S.Kaleesuwari Refinery Pvt. Ltd. filed a civil suit against Sri Durgai Oil Stores alleging infringement of its 'Gold Winner' trademark and copyright related to edible sunflower oil packaging. The plaintiff sought permanent injunctions and damages for using deceptively similar marks like 'Son Gold'. However, the court noted that this matter had already been decreed by a Division Bench in 2019 based on the defendant's affidavit agreeing to cease such activities. Consequently, the current suit was dismissed as nothing remained to be adjudicated.

Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →

Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.

Strategy Consult

Facing a similar patent matter?

Arctic's litigation team uses precedent data like this to build winning arguments.

Get a Strategy Call